# Andrew Plump

> Andrew Plump is a corporate round investor at Takeda backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Takeda](https://shizune.co/investors/profile/takeda-pharmaceutical)
- Location: Boston, United States
- Total investments: 1
- Last investment: Mar 2017
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/andy-plump-5479124

Andrew Plump is a corporate round investor at Takeda in Boston focused on Health Care and Biotechnology. Bachelor's degree, MIT; MD, University of California, San Francisco; PhD, Rockefeller University. Formerly: Senior Vice-President, Research & Translational Medicine, Deputy to the President of R&D, Sanofi; Vice-President, Worldwide Cardiovascular Research Head, Merck. Chief Medical and Scientific Officer and R&D Head, Takeda,leading drug discovery and development across Takeda’s core therapeutic areas, which include oncology, gastroenterology, CNS, cardiometabolic and vaccines.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Product Research | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Scohia Pharma | Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic. | $1.4B | Corporate Round | Mar 14, 2017 |  |

1 of 1 investments shown.

## Co-investors
- [Innovation Network Corporation of Japan](https://shizune.co/investors/profile/innovation-network-corp-of-japan) — VC Fund, 1 deal together
- [Medipal Holdings](https://shizune.co/investors/profile/medipal-holdings) — VC Fund, 1 deal together

## About Takeda

VC Fund · Osaka, Japan

Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.

5 contacts available at Takeda.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Plump | President, Research & Development | https://shizune.co/investors/profile/andrew-plump |
| Bin Li | Director of Computational Biology, Takeda Data Science Institute | https://shizune.co/investors/profile/bin-li |
| Ceri Davies | Head of CNS Drug Discovery Unit | https://shizune.co/investors/profile/ceri-davies-bcd7 |
| Christopher Barr | Takeda Community Engagement | https://shizune.co/investors/profile/christopher-barr |
| Masaru Otsuka | Head of Digital Acceleration | https://shizune.co/investors/profile/masaru-otsuka |

## Similar investors

### Similar stage
- [Info Edge](https://shizune.co/investors/profile/info-edge) — VC Fund
- [Vector](https://shizune.co/investors/profile/vector-inc-) — VC Fund
- [Akatsuki Games Inc.](https://shizune.co/investors/profile/akatsuki-3) — VC Fund

## FAQ

### What does Andrew Plump invest in?

Andrew Plump invests primarily in Health Care, Biotechnology and Product Research startups, most often at Corporate Round stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Andrew Plump last invest?

The most recent investment recorded for Andrew Plump closed in Mar 2017. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co